Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group

1. Martin, M.
2. Villar, A.
3. Sole-Calvo, A.
4. Gonzalez, R.
5. Massuti, B.
6. Lizon, J.
7. Camps, C.
8. Carrato, A.
9. Casado, A.
10. Candel, M.T.
11. Albanell, J.
12. Aranda, J.
13. Munarriz, B.
14. Campbell, J.
15. Diaz-Rubio, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDG260 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus